...
首页> 外文期刊>Stem Cell Reports >A Quantitative Proteomic Analysis of Hemogenic Endothelium Reveals Differential Regulation of Hematopoiesis by {SOX17}
【24h】

A Quantitative Proteomic Analysis of Hemogenic Endothelium Reveals Differential Regulation of Hematopoiesis by {SOX17}

机译:定量蛋白质组学分析通过{SOX17}揭示的造血内皮细胞的差异调节。

获取原文
           

摘要

Summary The in?vitro derivation of hematopoietic stem cells (HSCs) from pluripotent stem cells (PSCs) is complicated by the existence of multiple overlapping embryonic blood cell programs called primitive, erythromyeloid progenitor (EMP), and definitive. As {HSCs} are only generated during the definitive stage of hematopoiesis, deciphering the regulatory pathways that control the emergence of this program and identifying markers that distinguish it from the other programs are essential. To identify definitive specific pathways and marker sets, we used label-free proteomics to determine the proteome of embryo-derived and mouse embryonic stem cell-derived VE-CADHERIN+CD45? definitive hematopoietic progenitors. With this approach, we identified Stat1 as a marker that distinguishes the definitive erythroid lineage from the primitive- and EMP-derived lineages. Additionally, we provide evidence that the generation of the Stat1+ definitive lineage is dependent on Sox17. These findings establish an approach for monitoring the emergence of definitive hematopoiesis in the {PSC} differentiation cultures.
机译:小结由于存在多种重叠的胚胎血细胞程序,称为原始,红血球祖细胞(EMP)和定型的,从多能干细胞(PSC)的体外衍生造血干细胞(HSC)变得复杂。由于{HSCs}仅在造血的确定阶段产生,因此破译控制该程序出现的调节途径并确定将其与其他程序区分开的标记至关重要。为了确定确定的特定途径和标记集,我们使用了无标记蛋白质组学来确定胚胎来源和小鼠胚胎干细胞来源的VE-CADHERIN + CD45的蛋白质​​组。确定的造血祖细胞。通过这种方法,我们将Stat1识别为标志物,以将确定性的类红细胞谱系与原始和EMP谱系区分开。此外,我们提供的证据表明Stat1 +最终谱系的生成取决于Sox17。这些发现建立了一种监测{PSC}分化培养物中确定性造血功能出现的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号